Advertising Disclaimer
eLetters is an online forum for ongoing peer review. To submit an eLetter please go to the article you wish to respond to and click on the link that reads "eLetters: Submit an Eletter." Submission of eLetters are open to all health care professionals and experts in related fields.

eLetters to:

SPECIAL ARTICLE:
Hanoch A. Patt and Ralph D. Feigin
Diagnosis and Management of Suspected Cases of Bioterrorism: A Pediatric Perspective
Pediatrics 2002; 109: 685-692 [Abstract] [Full text] [PDF]
*eLetters: Submit a response to this article

eLetters published:

[Read eLetters] Untitled
Ravi R Jhaveri   (28 May 2002)

Untitled 28 May 2002
Top
Ravi R Jhaveri,
Pediatric Infectious Disease fellow
Mattel Children's Hospital at UCLA

Send letter to journal:
Re: this article

rjhaveri{at}ucla.edu Ravi R Jhaveri

I am sure to be late in pointing this out. I was recently going through the April issue of Pediatrics, specifically the article on Bioterrorism:a pediatric perspective by Drs. Patt and Feigin. On pg. 687 in the last paragraph of the section on Anthrax, Clindamycin is referred to as an inhibitor of DNA synthesis. It is of course a protein synthesis inhibitor as the authors are I am sure well aware given the context in which the sentence was written. It would be important to reiterate this point to the general physician since Clindamycin has a role in other diseases to halt toxin production (Staphylococcal toxin-mediated illness).